DKSH Business Unit Healthcare, the leading Market Expansion Services provider, today announced a strategic collaboration with life sciences leader Bayer to distribute and market its cardiovascular and women’s health product portfolios.

This distribution will be focused in four major Southeast Asian markets: Singapore, Malaysia, Thailand, and the Philippines.

The partnership will target Bayer’s cardiovascular portfolio in all four markets as well as its women’s health retail portfolio in Thailand in particular.

The deal is a major milestone toward enhancing patient access and healthcare delivery in the region using an end-to-end distribution and promotion model.

Key Highlights-

• DKSH and Bayer form strategic partnership to boost healthcare access in Southeast Asia
• Collaboration covers cardiovascular and women’s health products across four key markets
• Focus on end-to-end distribution, improved patient outcomes, and regional market growth

Ashraf Al-Ouf, Head of Commercial Operations, Bayer Pharmaceuticals APAC  said, “DKSH’s deep healthcare knowledge and strong commercial strength in Southeast Asia make them an excellent partner for us, particularly in Malaysia, the Philippines, Singapore, and Thailand. Together, we are poised to manage the dynamic market environment, foster sustainable growth, and improve patient outcomes and accessibility in the region.”

ALSO READ: Southeast Asia Is the Next Global Manufacturing Hotspot – What You Need to Know

DKSH will utilize its robust infrastructure, rich experience in cardiovascular care, and combined commercial and medical affairs capabilities to facilitate effective market delivery and healthcare professional interaction.

Bijay Singh, Global Head of Business Unit Healthcare at DKSH, said, “We are excited to start this collaboration with Bayer. We are particularly pleased Bayer selected DKSH to enhance their go-to-market business model. We believe we can drive increased patient access while maintaining compliance and quality.”

The collaboration underscores both companies’ mutual passion for building Southeast Asia’s healthcare ecosystem and providing better patient outcomes.